Cargando…

Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach

OBJECTIVE: To determine patient experience and perception following a diagnosis of non‐muscle‐invasive bladder cancer (NMIBC). PATIENT AND METHODS: Patients were part of a prospective multicentre observational study recruiting patients with NMIBC for a urine biomarker study (DETECT II; ClinicalTrial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wei Shen, Teo, Chin Hai, Chan, Delcos, Ang, Kar Mun, Heinrich, Malgorzata, Feber, Andrew, Sarpong, Rachael, Williams, Norman, Brew‐Graves, Chris, Ng, Chirk Jenn, Kelly, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318301/
https://www.ncbi.nlm.nih.gov/pubmed/31975539
http://dx.doi.org/10.1111/bju.15008
_version_ 1783550815514918912
author Tan, Wei Shen
Teo, Chin Hai
Chan, Delcos
Ang, Kar Mun
Heinrich, Malgorzata
Feber, Andrew
Sarpong, Rachael
Williams, Norman
Brew‐Graves, Chris
Ng, Chirk Jenn
Kelly, John
author_facet Tan, Wei Shen
Teo, Chin Hai
Chan, Delcos
Ang, Kar Mun
Heinrich, Malgorzata
Feber, Andrew
Sarpong, Rachael
Williams, Norman
Brew‐Graves, Chris
Ng, Chirk Jenn
Kelly, John
author_sort Tan, Wei Shen
collection PubMed
description OBJECTIVE: To determine patient experience and perception following a diagnosis of non‐muscle‐invasive bladder cancer (NMIBC). PATIENT AND METHODS: Patients were part of a prospective multicentre observational study recruiting patients with NMIBC for a urine biomarker study (DETECT II; ClinicalTrials.gov: NCT02781428). A mixed‐methods approach comprising: (i) the Brief Illness Perception Questionnaire (Brief‐IPQ) and (ii) semi‐structured interviews to explore patients’ experience of having haematuria, and initial and subsequent experience with a NMIBC diagnosis. Both assessments were completed at 6 months after NMIBC diagnosis. RESULTS: A total of 213 patients completed the Brief‐IPQ. Patients felt that they had minimal symptoms (median [interquartile range, IQR] score 2 [0–5]) and were not particularly affected emotionally (median [IQR] score 3 [1–6]) with a minimal effect to their daily life (median [IQR] score 2 [0–5]). However, they remained concerned about their cancer diagnosis (median [IQR] score 5 [3–8]) and felt that they had no personal control over the cancer (median [IQR] score 2 [2–5]) and believed that their illness would affect them for some time (median [IQR] score 6 [3–10]). A significant association with a lower personal control of the disease (P < 0.05) and a poorer understanding of the management of NMIBC (P < 0.05) was seen in patients aged >70 years. Many patients were uncertain about the cause of bladder cancer. Qualitative analysis found that at initial presentation of haematuria, most patients were not aware of the risk of bladder cancer. Patients were most anxious and psychologically affected between the interval of cystoscopy diagnosis and transurethral resection of bladder tumour (TURBT). Following TURBT, most patients were positive about their cancer prognosis. CONCLUSION: Patients with NMIBC have a poor perception of disease control and believe that their disease will continue over a prolonged period of time. This is particularly more pertinent in the elderly. Patients are most psychologically affected during the interval between cancer diagnosis following cystoscopy and TURBT. Health awareness about bladder cancer remained poor with a significant number of patients unaware of the causes of bladder cancer. Psychological support and prompt TURBT following bladder cancer diagnosis would help improve the mental health of patients with NMIBC.
format Online
Article
Text
id pubmed-7318301
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73183012020-06-29 Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach Tan, Wei Shen Teo, Chin Hai Chan, Delcos Ang, Kar Mun Heinrich, Malgorzata Feber, Andrew Sarpong, Rachael Williams, Norman Brew‐Graves, Chris Ng, Chirk Jenn Kelly, John BJU Int Trial OBJECTIVE: To determine patient experience and perception following a diagnosis of non‐muscle‐invasive bladder cancer (NMIBC). PATIENT AND METHODS: Patients were part of a prospective multicentre observational study recruiting patients with NMIBC for a urine biomarker study (DETECT II; ClinicalTrials.gov: NCT02781428). A mixed‐methods approach comprising: (i) the Brief Illness Perception Questionnaire (Brief‐IPQ) and (ii) semi‐structured interviews to explore patients’ experience of having haematuria, and initial and subsequent experience with a NMIBC diagnosis. Both assessments were completed at 6 months after NMIBC diagnosis. RESULTS: A total of 213 patients completed the Brief‐IPQ. Patients felt that they had minimal symptoms (median [interquartile range, IQR] score 2 [0–5]) and were not particularly affected emotionally (median [IQR] score 3 [1–6]) with a minimal effect to their daily life (median [IQR] score 2 [0–5]). However, they remained concerned about their cancer diagnosis (median [IQR] score 5 [3–8]) and felt that they had no personal control over the cancer (median [IQR] score 2 [2–5]) and believed that their illness would affect them for some time (median [IQR] score 6 [3–10]). A significant association with a lower personal control of the disease (P < 0.05) and a poorer understanding of the management of NMIBC (P < 0.05) was seen in patients aged >70 years. Many patients were uncertain about the cause of bladder cancer. Qualitative analysis found that at initial presentation of haematuria, most patients were not aware of the risk of bladder cancer. Patients were most anxious and psychologically affected between the interval of cystoscopy diagnosis and transurethral resection of bladder tumour (TURBT). Following TURBT, most patients were positive about their cancer prognosis. CONCLUSION: Patients with NMIBC have a poor perception of disease control and believe that their disease will continue over a prolonged period of time. This is particularly more pertinent in the elderly. Patients are most psychologically affected during the interval between cancer diagnosis following cystoscopy and TURBT. Health awareness about bladder cancer remained poor with a significant number of patients unaware of the causes of bladder cancer. Psychological support and prompt TURBT following bladder cancer diagnosis would help improve the mental health of patients with NMIBC. John Wiley and Sons Inc. 2020-02-12 2020-05 /pmc/articles/PMC7318301/ /pubmed/31975539 http://dx.doi.org/10.1111/bju.15008 Text en © 2020 The Authors BJU International Published by John Wiley & Sons Ltd on behalf of BJU International. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Trial
Tan, Wei Shen
Teo, Chin Hai
Chan, Delcos
Ang, Kar Mun
Heinrich, Malgorzata
Feber, Andrew
Sarpong, Rachael
Williams, Norman
Brew‐Graves, Chris
Ng, Chirk Jenn
Kelly, John
Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
title Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
title_full Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
title_fullStr Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
title_full_unstemmed Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
title_short Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
title_sort exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
topic Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318301/
https://www.ncbi.nlm.nih.gov/pubmed/31975539
http://dx.doi.org/10.1111/bju.15008
work_keys_str_mv AT tanweishen exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT teochinhai exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT chandelcos exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT angkarmun exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT heinrichmalgorzata exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT feberandrew exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT sarpongrachael exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT williamsnorman exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT brewgraveschris exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT ngchirkjenn exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT kellyjohn exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach
AT exploringpatientsexperienceandperceptionofbeingdiagnosedwithbladdercanceramixedmethodsapproach